Lipid Handling Protein Gene Expression in Colorectal Cancer: CD36 and Targeting MiRNAs

Overview

Journal Life (Basel)

Specialty Biology

Date 2022 Dec 23

PMID 36556492

Authors

Andrei Marian Niculae

Maria Dobre

Vlad Herlea

Florina Vasilescu

Laura Cristina Ceafalan

Bogdan Trandafir

Elena Milanesi

Mihail Eugen Hinescu

Affiliations

Soon will be listed here.

Abstract

The reprogramming of lipid metabolism has been highlighted in colorectal cancer (CRC) studies, suggesting a critical role for the scavenger receptor CD36 and fatty acid synthase (FASN) in this malignancy. In this study, we analyzed the gene expression levels of CD36, FASN, the cell surface glypican 4 (GPC4), and the two transporters SLC27A3 and SLC27A4 in 39 paired tumoral and peritumoral tissues from patients with CRC compared with 18 normal colonic mucosae. Moreover, the levels of seven miRNAs targeting CD36 and most of the analyzed genes were evaluated. We found a significant impairment of the expression of all the analyzed genes except GPC4 as well as the differential expression of miR-16-5p, miR-26b-5p, miR-107, miR-195-5p, and miR-27a-3p in the colonic mucosa of CRC patients. Interestingly, CD36 and miR-27a-3p were downregulated and upregulated, respectively, in tumoral tissues compared to peritumoral and control tissues, with a significant negative correlation in the group of patients developing lymph node metastasis. Our results sustain the relationship between CRC and fatty acid metabolism and emphasize the importance of related miRNAs in developing new therapeutic strategies.

Citing Articles

Colorectal Cancer: Pathogenesis and Targeted Therapy.

Li J, Pan J, Wang L, Ji G, Dang Y MedComm (2020). 2025; 6(3):e70127.

PMID: 40060193 PMC: 11885891. DOI: 10.1002/mco2.70127.

Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma.

Poenaru R, Milanesi E, Niculae A, Dobre A, Vladut C, Ciocirlan M World J Gastrointest Oncol. 2025; 17(1):98409.

PMID: 39817147 PMC: 11664611. DOI: 10.4251/wjgo.v17.i1.98409.

Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism.

Li B, Mi J, Yuan Q Cell Death Discov. 2024; 10(1):350.

PMID: 39103344 PMC: 11300464. DOI: 10.1038/s41420-024-02126-9.

SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer.

Zhang D, Fang J, Shan J, Xu L, Wu Y, Lu B Breast Cancer Res Treat. 2024; 207(1):15-24.

PMID: 38914918 DOI: 10.1007/s10549-024-07401-y.

Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing.

Holubekova V, Loderer D, Grendar M, Mikolajcik P, Kolkova Z, Turyova E Front Oncol. 2023; 13:1206482.

PMID: 37869102 PMC: 10586664. DOI: 10.3389/fonc.2023.1206482.

References

Rapuano R, Ziccardi P, Cioffi V, Dallavalle S, Moricca S, Lupo A . Cladosporols A and B, two natural peroxisome proliferator-activated receptor gamma (PPARγ) agonists, inhibit adipogenesis in 3T3-L1 preadipocytes and cause a conditioned-culture-medium-dependent arrest of HT-29 cell proliferation. Biochim Biophys Acta Gen Subj. 2021; 1865(11):129973. DOI: 10.1016/j.bbagen.2021.129973. View

Coleman O, Ecker M, Haller D . Dysregulated lipid metabolism in colorectal cancer. Curr Opin Gastroenterol. 2022; 38(2):162-167. DOI: 10.1097/MOG.0000000000000811. View

Hale J, Otvos B, Sinyuk M, Alvarado A, Hitomi M, Stoltz K . Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014; 32(7):1746-58. PMC: 4063873. DOI: 10.1002/stem.1716. View

Jafari N, Drury J, Morris A, Onono F, Stevens P, Gao T . Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer. Mol Cancer Res. 2018; 17(1):140-152. PMC: 6318071. DOI: 10.1158/1541-7786.MCR-18-0199. View

Enciu A, Radu E, Popescu I, Hinescu M, Ceafalan L . Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?. Biomed Res Int. 2018; 2018:7801202. PMC: 6057354. DOI: 10.1155/2018/7801202. View

Niculite C, Enciu A, Hinescu M . CD 36: Focus on Epigenetic and Post-Transcriptional Regulation. Front Genet. 2019; 10:680. PMC: 6659770. DOI: 10.3389/fgene.2019.00680. View

Kara M, Yumrutas O, Ozcan O, Celik O, Bozgeyik E, Bozgeyik I . Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015; 567(1):81-6. DOI: 10.1016/j.gene.2015.04.065. View

Fhu C, Ali A . Fatty Acid Synthase: An Emerging Target in Cancer. Molecules. 2020; 25(17). PMC: 7504791. DOI: 10.3390/molecules25173935. View

Pei Z, Fraisl P, Berger J, Jia Z, Forss-Petter S, Watkins P . Mouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J Biol Chem. 2004; 279(52):54454-62. DOI: 10.1074/jbc.M410091200. View

10.

Zaytseva Y, Rychahou P, Gulhati P, Elliott V, Mustain W, OConnor K . Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res. 2012; 72(6):1504-17. PMC: 3596828. DOI: 10.1158/0008-5472.CAN-11-4057. View

11.

Luo Q, Zhang Z, Dai Z, Basnet S, Li S, Xu B . Tumor-suppressive microRNA-195-5p regulates cell growth and inhibits cell cycle by targeting cyclin dependent kinase 8 in colon cancer. Am J Transl Res. 2016; 8(5):2088-96. PMC: 4891422. View

12.

Czumaj A, Zabielska J, Pakiet A, Mika A, Rostkowska O, Makarewicz W . Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation. Anticancer Res. 2019; 39(7):3815-3822. DOI: 10.21873/anticanres.13531. View

13.

Fang Y, Shen Z, Zhan Y, Feng X, Chen K, Li Y . CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019; 10(1):3981. PMC: 6726635. DOI: 10.1038/s41467-019-11662-3. View

14.

Gomez de Cedron M, Ramirez de Molina A . Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. J Lipid Res. 2015; 57(2):193-206. PMC: 4727429. DOI: 10.1194/jlr.R061812. View

15.

Lee K, Lee M, Cha E, Sul J, Lee J, Kim J . Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis. Mol Med Rep. 2017; 15(4):2163-2173. PMC: 5364834. DOI: 10.3892/mmr.2017.6254. View

16.

Lu T, Sun L, Wang Z, Zhang Y, He Z, Xu C . Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway. Onco Targets Ther. 2019; 12:3339-3347. PMC: 6504633. DOI: 10.2147/OTT.S199369. View

17.

Kim S, Kim A, Lee H, Son Y, Lee G, Lee J . miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun. 2010; 392(3):323-8. DOI: 10.1016/j.bbrc.2010.01.012. View

18.

Guo J, Fang W, Sun L, Lu Y, Dou L, Huang X . Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. Nat Commun. 2018; 9(1):612. PMC: 5807361. DOI: 10.1038/s41467-018-03072-8. View

19.

Xu Y, Shen L, Li F, Yang J, Wan X, OuYang M . microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J Cell Physiol. 2019; 234(11):21380-21394. DOI: 10.1002/jcp.28747. View

20.

Liu F, Liu S, Ai F, Zhang D, Xiao Z, Nie X . miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4). Oncol Res. 2016; 25(6):967-974. PMC: 7841080. DOI: 10.3727/096504016X14803476672380. View